クレアチニン測定法市場 - 世界の産業規模、シェア、動向、機会、予測、検査タイプ別、製品別、サンプル別、エンドユーザー別、地域別、競合別、2020～2030年

世界のクレアチニン測定法市場は、2024年に6億4,029万米ドルと評価され、予測期間中のCAGRは7.48%で、2030年には9億8,715万米ドルに達すると予測されています。

クレアチニン測定検査は、人体の腎機能を評価するために行われます。クレアチニンは、筋肉でのエネルギー生産後に体内に残る化学化合物です。血液や尿サンプル中のクレアチニン濃度を測定することで、クレアチニンをろ過する腎臓の状態を知ることができます。成人の場合、クレアチニンの正常値は血液1デシリットル当たり0.5～1.2ミリグラムです。クレアチニンの値が高いほど、腎臓が不健康な状態であることを示しています。特に発展途上諸国では、不利な生活環境のために、世界中で腎臓病の有病率が増加しており、クレアチニン測定検査の需要が高まっています。さらに、検査キットや試薬の費用対効果や入手のしやすさも市場成長に寄与しています。

市場促進要因

腎臓関連の健康問題の増加

主な市場課題

クレアチニン検査法に関する認識不足

主な市場動向

ポイントオブケア検査

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のクレアチニン測定法市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 検査タイプ別（Jaffe速度論法、酵素法）
  • 製品別（試薬、キット）
  • サンプル別（血液/血清、尿）
  • エンドユーザー別（病院、診断研究所）
  • 地域別
  • 企業別（2024年）
• 市場マップ

第6章 北米のクレアチニン測定法市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のクレアチニン測定法市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域のクレアチニン測定法市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のクレアチニン測定法市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのクレアチニン測定法市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

第13章 世界のクレアチニン測定法市場：SWOT分析

第14章 競合情勢

• Abbott Laboratories
• Thermo Fisher Scientific
• Merck KGaA
• Quidel Corporation
• Cell Biolabs, Inc.
• Genway Biotech
• Randox Laboratories Ltd.
• ACON Laboratories
• Nova Biomedical
• Sysmex India Pvt. Ltd.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Creatinine Assay Market was valued at USD 640.29 Million in 2024 and is expected to reach USD 987.15 Million by 2030 with a CAGR of 7.48% during the forecast period. The creatinine measurement test is performed to assess renal function in the human body. Creatinine is a chemical compound that remains in the body after energy production in the muscles. By measuring creatinine levels in blood and urine samples, the status of the kidneys can be determined as they filter out creatinine. In adults, a normal creatinine measurement ranges from 0.5 to 1.2 milligrams per deciliter of blood. Higher levels of creatinine indicate unhealthy kidney conditions. The increasing prevalence of kidney diseases worldwide, particularly in developing countries, due to unfavorable living conditions, has led to a growing demand for creatinine measurement tests. Additionally, the cost-effectiveness and easy availability of test kits and reagents are contributing to market growth.

Key Market Drivers

Growing Kidney Related Health Problems

Kidney disorder, particularly chronic kidney disease (CKD), is a prominent contributor to global mortality rates. Timely diagnosis and appropriate treatment are crucial in preventing complications. Creatinine testing methods are employed to assess renal functionality. Key market players are prioritizing the production of high-quality products to meet the growing demand. Additionally, the continual increase in research activities in this field is propelling the global market's expansion. With an increasing number of people being diagnosed with kidney-related diseases, there is a higher demand for creatinine testing to assess kidney function and monitor disease progression. Patients with kidney diseases require regular monitoring of their kidney function, including creatinine levels. This ongoing monitoring drives the need for frequent creatinine testing. Creatinine assays are routinely performed in hospitals, clinics, and other healthcare facilities to assess kidney function in patients admitted with kidney-related issues or undergoing treatments that may impact kidney function. The need for rapid results and immediate clinical decision-making in critical care settings has driven the adoption of point-of-care creatinine testing, allowing for timely patient management. In the pharmaceutical industry, creatinine assays are utilized in pre-clinical and clinical research to assess the impact of new drugs on kidney function and potential nephrotoxicity. As awareness about kidney health increases, more people are undergoing routine health check-ups that include creatinine testing to identify early signs of kidney dysfunction which is boosting the global creatinine assay market.

Key Market Challenges

Lack Of Awareness About Creatinine Testing Methods

Many patients may not be aware of the importance of creatinine testing in assessing kidney function and may not understand its significance in their overall health. Different healthcare settings may use various methods for creatinine testing, leading to confusion among patients and providers about the accuracy and reliability of results. In some cases, healthcare providers may prioritize other health parameters over creatinine testing, potentially overlooking early signs of kidney dysfunction. Public health initiatives and awareness campaigns may not adequately address the importance of kidney health and creatinine testing in promoting overall well-being.

Key Market Trends

Point-of-Care Testing

POCT can be performed at the patient's bedside, in outpatient clinics, or even in remote or resource-limited areas. It eliminates the need for patients to visit a centralized laboratory for creatinine testing, enhancing accessibility to diagnostic services. For patients with chronic kidney disease (CKD) or those undergoing treatments that may impact kidney function, POCT allows for frequent and easy monitoring of creatinine levels, enabling timely adjustments to treatment plans. In telemedicine or remote healthcare settings, POCT of creatinine allows for remote monitoring of kidney function, promoting continuity of care and personalized treatment plans. POCT can lead to cost savings by reducing the need for multiple visits or sample transportation to centralized laboratories.

Key Market Players

• Abbott Laboratories
• Thermo Fisher Scientific
• Merck KGaA
• Quidel Corporation
• Cell Biolabs, Inc.
• Genway Biotech
• Randox Laboratories Ltd.
• ACON Laboratories
• Nova Biomedical
• Sysmex India Pvt. Ltd.

Report Scope:

In this report, the Global Creatinine Assay Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Creatinine Assay Market, By Test Type:

• Jaffe Kinetic Method
• Enzymatic Method

Creatinine Assay Market, By Product:

• Reagents
• Kits

Creatinine Assay Market, By Sample:

• Blood/Serum
• Urine

Creatinine Assay Market, By End User:

• Hospitals
• Diagnostic Laboratories

Creatinine Assay Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Creatinine Assay Market.

Available Customizations:

Global Creatinine Assay market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Creatinine Assay Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Test Type (Jaffe Kinetic Method, Enzymatic Method)
  • 5.2.2. By Product (Reagents, Kits)
  • 5.2.3. By Sample (Blood/Serum, Urine)
  • 5.2.4. By End User (Hospitals, Diagnostic Laboratories)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Creatinine Assay Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Test Type
  • 6.2.2. By Product
  • 6.2.3. By Sample
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Creatinine Assay Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Test Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Sample
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Creatinine Assay Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Test Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Sample
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Creatinine Assay Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Test Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Sample
      • 6.3.3.2.4. By End User

7. Europe Creatinine Assay Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Test Type
  • 7.2.2. By Product
  • 7.2.3. By Sample
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Creatinine Assay Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Test Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Sample
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Creatinine Assay Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Test Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Sample
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy Creatinine Assay Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Test Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Sample
      • 7.3.3.2.4. By End User
  • 7.3.4. France Creatinine Assay Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Test Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Sample
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Creatinine Assay Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Test Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Sample
      • 7.3.5.2.4. By End User

8. Asia-Pacific Creatinine Assay Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Test Type
  • 8.2.2. By Product
  • 8.2.3. By Sample
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Creatinine Assay Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Test Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Sample
      • 8.3.1.2.4. By End User
  • 8.3.2. India Creatinine Assay Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Test Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Sample
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Creatinine Assay Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Test Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Sample
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Creatinine Assay Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Test Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Sample
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Creatinine Assay Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Test Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Sample
      • 8.3.5.2.4. By End User

9. South America Creatinine Assay Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Test Type
  • 9.2.2. By Product
  • 9.2.3. By Sample
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Creatinine Assay Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Test Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Sample
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Creatinine Assay Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Test Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Sample
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Creatinine Assay Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Test Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Sample
      • 9.3.3.2.4. By End User

10. Middle East and Africa Creatinine Assay Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Test Type
  • 10.2.2. By Product
  • 10.2.3. By Sample
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Creatinine Assay Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Test Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Sample
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Creatinine Assay Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Test Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Sample
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Creatinine Assay Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Test Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Sample
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

13. Global Creatinine Assay Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Abbott Laboratories
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Thermo Fisher Scientific
• 14.3. Merck KGaA
• 14.4. Quidel Corporation
• 14.5. Cell Biolabs, Inc.
• 14.6. Genway Biotech
• 14.7. Randox Laboratories Ltd.
• 14.8. ACON Laboratories
• 14.9. Nova Biomedical
• 14.10. Sysmex India Pvt. Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer